Rheumatoid Arthritis Therapy With Genetically Engineered Biological Agents in the Republic of Karelia

Modern Rheumatology Journal
doi 10.14412/1996-7012-2013-2446
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Use of Genetically Engineered Biological Drugs for Rheumatoid Arthritis in the Russian Federation

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2012English

Efficacy of Genetically Engineered Biological Agents in the Treatment of Uveitis Associated With Rheumatic Diseases in Children

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2012English

Pharmacoeconomic Analysis of Using Biological Agents in the Treatment of Rheumatoid Arthritis

Modern Rheumatology Journal
2014English

Biological Therapy and Infection in Rheumatoid Arthritis Patients: Modern Aspects

Medical Council
2016English

PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Serum Anticyclic Citrullinated Protein Antibody Titers Are Correlated With the Response to Biological Agents in Patients With Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2014English

Persistence With Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2016English

Infections in Patients With Rheumatoid Arthritis Receiving Anti-Cytokine Therapy: Biological Mechanisms and Clinical Aspects

Reumatismo
Rheumatology
2011English

Rituximab Therapy in Greek Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy